Cleared Traditional

K090630 - NOBEL BIOCARE ENDOSSEOUS IMPLANTS (MAXI...

K090630 is the FDA 510(k) clearance for NOBEL BIOCARE ENDOSSEOUS IMPLANTS (MAXI... by Nobel Biocare AB. It is a Class 2 General & Plastic Surgery device (product code FZE) cleared through the Traditional 510(k) pathway after a 85-day FDA review.

K090630 · Nobel Biocare AB · General & Plastic Surgery device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jun 2009
Decision
85d
Days
Class 2
Risk

K090630 is an FDA 510(k) clearance for the NOBEL BIOCARE ENDOSSEOUS IMPLANTS (MAXILLOFACIAL INDICATION). Classified as Prosthesis, Nose, Internal (product code FZE), Class II - Special Controls.

Submitted by Nobel Biocare AB (Yorba Linda,, US). The FDA issued a Cleared decision on June 2, 2009 after a review of 85 days - a notably fast clearance cycle.

This device falls under the General & Plastic Surgery FDA review panel, regulated under 21 CFR 878.3680 - the FDA general and plastic surgery device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Nobel Biocare AB devices

Submission Details

510(k) Number K090630 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 09, 2009
Decision Date June 02, 2009
Days to Decision 85 days
Submission Type Traditional
Review Panel General & Plastic Surgery (SU)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
30d faster than avg
Panel avg: 115d · This submission: 85d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code FZE Prosthesis, Nose, Internal
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 878.3680
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General & Plastic Surgery devices follow this clearance model.

Regulatory Peers - FZE Prosthesis, Nose, Internal

All 12
Devices cleared under the same product code (FZE) and FDA review panel - the closest regulatory comparables to K090630.
Medicon Epiplating System
K241253 · Cmf Medicon Surgical, Inc. · Dec 2024
IMPLANTECH JEJ PERI-PYRIFORM IMPLANT
K962824 · Implantech Associates, Inc. · Oct 1996
BA-CPAS
K945154 · Nobelpharma USA, Inc. · Jan 1995
IMPLANTECH DORSAL COLUMELLA IMPLANT STYLE II
K941960 · Implantech Associates, Inc. · Aug 1994
IMPLANTECH DORSAL NASAL IMPLANT
K942876 · Implantech Associates, Inc. · Jul 1994
NASAL DORSUM
K925743 · Smith & Nephew Richards, Inc. · Aug 1993